Research programme: growth hormone releasing factor analogues - Theratechnologies
Alternative Names: GHRF analogues - Theratechnologies; GRF analogues; TH 1173Latest Information Update: 30 Jan 2013
At a glance
- Originator Theratechnologies
- Class Peptide hormones; Pituitary hormone releasing hormones
- Mechanism of Action Growth hormone releasing factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Endocrine disorders
Most Recent Events
- 01 Jan 2013 Suspended - Preclinical for Endocrine disorders in Canada (unspecified route)
- 06 Oct 2011 Preclinical trials in Endocrine disorders in Canada (unspecified route)
- 01 Jan 2011 Early research in Endocrine disorders in Canada (unspecified route)